CoChat

Apolipoprotein E and Alzheimer's Disease A Rapidly Expanding Field with Medical and Epidemiological Consequences

ROSES, ALLEN D. · 1996 · Annals of the New York Academy of Sciences
Cited by 78

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The Alzheimer's Association and the National Institute on Aging sponsored a meeting of experts in Alzheimer's disease (AD), geneticists, social scientists, and ethicists in Chicago in October 1995 to discuss the use of apolipoprotein E (APOE) genotyping in Alzheimer's disease. A short scientific report was published in the scientific journal Lancet with recommendations from the group. Several areas were discussed, including: (1) the scientific basis for recommendations on the application and uses of APOE genotyping, (2) clarifying the clinical and epidemiological research that needs to done, (3) genetic counseling issues, (4) ethical and legal issues, and (5) potential uses of APOE genotyping for treatment care planning. This contribution was a general introduction to begin the meeting. The genetic association of APOE genotypes with the age of onset distribution and risk of Alzheimer's disease was reviewed. An analysis of the current applications for three distinctly different applications of APOE genotyping was presented with the following conclusions: (1) predictive testing for cognitively intact persons was not recommended; (2) APOE genotyping is a promising adjunct for use in the differential diagnosis of patients with dementia; and (3) APOE genotyping may have a use in selecting therapies; however, further prospective studies are necessary. There is no universal "APOE test for AD." A strong emphasis was made to avoid use of the term in making recommendations regarding APOE genotyping without specific reference to the type of application involved. The predictive testing of asymptomatic persons versus APOE genotyping as a diagnostic adjunct for symptomatic patients has been seriously confused in both the lay and clinical press. The former application is not recommended, but diagnostic usefulness early in clinical evaluations for dementia has been confirmed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.1996.tb32598.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 78

Metadata

Authors
ROSES, A. D.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
1996-12
Volume
802
Issue
1
Pages
50-57
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W2089442400
Cited by
78
References
2
FWCI
1.78
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Apolipoprotein E and Alzheimer's Disease A Rapidly Expanding Field with Medical and Epidemiological Consequences. https://app.cochat.ai/papers/10.1111/j.1749-6632.1996.tb32598.x
The paper
ROSES, A. D. (1996). Apolipoprotein E and Alzheimer's Disease A Rapidly Expanding Field with Medical and Epidemiological Consequences. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1996.tb32598.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.